Implementation and application of methods for pathogen identification from clinical respiratory samples based on high-throughput sequencing

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034651

Enrollment

100

Registered

2025-03-10

Start date

2024-11-04

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

respiratory diseases

Interventions

Group 1: Persons without respiratory symptoms 2 nasopharyngeal swabs are taken once and analyzed for the pathogen spectrum within the sample using NGS Group 2: Persons with respiratory symptoms 2 naso

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: signed written consent

Exclusion criteria

Exclusion criteria: 1. Individuals who are unable to provide consent 2. Antibiotic therapy in the last 6 weeks

Design outcomes

Primary

Measure	Time frame
establish and apply molecular biology techniques at the DNA and RNA Ievel to detect pathogen spectra in clinical samples of the respiratory tract (nasopharyngeal swabs)	—

Countries

Germany

Contacts

Public ContactAndreas Wieser

Fraunhofer ITMP IIP

wieser@mvp.lmu.de089440059870

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026